Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02119650
Title Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Incyte Corporation
Indications

lung non-small cell carcinoma

Therapies

Cisplatin + Pemetrexed Disodium + Ruxolitinib

Cisplatin + Pemetrexed Disodium

Age Groups: adult
Covered Countries USA


No variant requirements are available.